Pfizer Inc. (NYSE: PFE) reported Monday with strong Phase 3 interim efficacy data for its coronavirus vaccine candidate.The Pfizer Analysts: Morgan Stanley analyst David Risinger has an Equal-weight rating […] Click here to view full article